Opus Genetics, Inc. (IRD) Tops Q2 EPS by 2c

Opus Genetics, Inc. (NASDAQ: IRD) reported Q2 EPS of ($0.14), $0.02 better than the analyst estimate of ($0.16).

For earnings history and earnings-related data on Opus Genetics, Inc. (IRD) click here.

You May Also Be Interested In

• Microsoft plans data center push to triple its computing power - Bloomberg
• UBS Upgrades Challenger (CGF:AU) (CFIGY) to Buy
• Zumiez, Inc. (ZUMZ) Misses Q2 EPS by 6c, Misses on Revenue; Offers Q3 Guidance